Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
4771.TW
STRONG BUYREMOVEVizionfocus Inc. · Healthcare · Taiwan · $357M · Avg Vol: $2M/d
Vizionfocus is a Taiwanese healthcare/contact lens manufacturer. It lacks any connection to our high-conviction macro themes and does not possess the scale or global moat required for our concentrated book.
COMPANY DESCRIPTION
Vizionfocus Inc. manufactures contact lenses and ophthalmic medical devices. The company utilizes advanced automated cast-molding technology and proprietary material formulations to produce high-comfort daily disposable lenses. It is a niche medical instruments manufacturer expanding rapidly in the global contact lens ODM market.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | — | 58.0M | 81.3M | 94.9M | 110.2M | 23.9% |
| EPS | 0.15 | 0.19 | 0.34 | 0.37 | — | 36.5% |
| Shares | — | 52.0M | 52.5M | 57.9M | 58.5M | +12.5% |
| Debt | — | 24.1M | 54.6M | 42.2M | 50.1M | 27.6% |
| Equity | — | 51.8M | 56.5M | 111.6M | 125.9M | 34.5% |
| Op CF | — | 23.9M | 30.3M | 36.0M | 34.0M | 12.4% |
| Inv CF | — | -9.1M | -44.0M | -38.0M | -39.9M | — |
| Fin CF | — | -4.2M | 10.3M | 13.5M | -0.5M | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 4771.TW are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 4771.TW | Vizionfocus Inc.(you) | $357M | 87 | STRONG BUY |
| 6782.TW | Visco Vision Inc. | $393M | 99 | STRONG BUY |
| 4107.TWO | Bioteque Corporation | $254M | 95 | STRONG BUY |
| 4126.TWO | Pacific Hospital Supply Co., Ltd | $184M | 86 | STRONG BUY |
| 6491.TW | Pegavision Corporation | $794M | 87 | STRONG BUY |
| 1783.TW | Maxigen Biotech Inc. | $109M | 80 | STRONG BUY |
| 1565.TWO | St.Shine Optical Co.,Ltd. | $149M | 63 | HOLD |
| 6527.TWO | Crystalvue Medical Corporation | $57M | 81 | STRONG BUY |
| 9103.TW | Medtecs International Corporation Limited | $90M | 65 | BUY |
| 1752.TW | Nang Kuang Pharmaceutical Co., Ltd. | $104M | 62 | HOLD |
Peer medians: ROE 3.4% · P/E 16.4x · Gross margin 42.1%